Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.
Insulin resistance, which implies impairment of insulin signaling in the target tissues, is a common cause of type 2 diabetes. Adipose tissue plays an important role in insulin resistance through the dysregulated production and secretion of adipose-derived proteins, including tumor necrosis factor-alpha, plasminogen activator inhibitor-1, leptin, resistin, angiotensinogen, and adiponectin. Adiponectin was estimated to be a protective adipocytokine against atherosclerosis, and also to have an anti-inflammatory effect. In this study, the relationship between fasting plasma adiponectin concentration and adiposity, body composition, insulin sensitivity (ITT, HOMAIR, QUICK), lipid profile, fasting insulin concentration were examined in Korean type 2 diabetes. The difference in the adiponectin concentrations was also examined in diabetic and non-diabetic subjects, with adjustment for gender, age and body mass index. 102 type 2 diabetics and 50 controls were examined. After a 12-h overnight fast, all subjects underwent a 75 gram oral glucose tolerance test. Baseline blood samples were drawn for the determinations of fasting plasma glucose, insulin, adiponectin, total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol. The body composition was estimated using a bioelectric impedance analyzer (Inbody 2.0). The insulin sensitivity was estimated using the insulin tolerance test (ITT), HOMAIR and QUICK methods. In the diabetic group, the fasting adiponectin concentrations were significantly lower in men than in women. They were negatively correlated with BMI (r=-0.453), hip circumference (r=-0.341), fasting glucose concentrations (r=-0.277) and HOMAIR (r= -0.233). In addition, they were positively correlated with systolic blood pressure (r=0.321) and HDL-cholesterol (r= 0.291). The systolic blood pressure and HDL-cholesterol were found to be independent variables, from a multiple logistic regression analysis, which influenced the adiponectin concentration. Compared with the non-diabetic group, the adiponectin concentrations were significantly lower in the diabetic group, with the exception of obese males. In conclusion, the plasma adiponectin concentrations were closely related to the insulin resistance parameters in Korean type 2 diabetic patients.
Kim
Mi-Jin
MJ
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Konkuk University, Seoul, Korea.
Yoo
Kwang-Ha
KH
Park
Hyung-Suk
HS
Chung
Sang-Man
SM
Jin
Choon-Jo
CJ
Lee
Yoen
Y
Shin
Young-Goo
YG
Chung
Choon-Hee
CH
D052242:Adiponectin; D000328:Adult; D000368:Aged; D015415:Biomarkers; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D007723:Korea; D008297:Male; D008875:Middle Aged
D052242:Adiponectin; D015415:Biomarkers; D036341:Intercellular Signaling Peptides and Proteins
Circulation. 1999 Dec 21-28;100(25):2473-6
10604883
J Biol Chem. 1996 May 3;271(18):10697-703
8631877
Diabetes Care. 2000 Jun;23(6):779-85
10840996
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1595-9
10845877
J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
10902785
Int J Obes Relat Metab Disord. 2000 Jul;24(7):861-8
10918532
Blood. 2000 Sep 1;96(5):1723-32
10961870
Biochem Biophys Res Commun. 1996 Apr 16;221(2):286-9
8619847
Nat Med. 1996 Jul;2(7):800-3
8673927
Cell. 1996 Nov 1;87(3):377-89
8898192
Diabetes. 1997 May;46(5):860-7
9133556
Curr Biol. 1998 Mar 12;8(6):335-8
9512423
Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
10092513
Circulation. 2000 Sep 12;102(11):1296-301
10982546
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2005-10
11172066
J Clin Endocrinol Metab. 2001 May;86(5):1930-5
11344187
Int J Exp Diabetes Res. 2000;1(2):81-8
11469400
Nat Med. 2001 Aug;7(8):941-6
11479627
Nat Med. 2001 Aug;7(8):947-53
11479628
J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9
11502817
Diabetes Care. 2002 Feb;25(2):376-80
11815513
Eur J Endocrinol. 2002 Aug;147(2):173-80
12153737
Diabetes. 2002 Sep;51(9):2734-41
12196466
Am J Epidemiol. 2002 Dec 1;156(11):1070-7
12446265
J Nephrol. 2002 Sep-Oct;15(5):507-11
12455716
Am J Hypertens. 2003 Jan;16(1):72-5
12517687
Metabolism. 2003 Oct;52(10):1274-8
14564678
Diabetes Res Clin Pract. 2004 Feb;63(2):135-42
14739054
Am J Physiol. 1979 Sep;237(3):E214-23
382871
Diabet Med. 1992 Jun;9(5):432-7
1611830
Diabetes Res Clin Pract. 1993 Jun;20(3):201-7
8404454
Diabet Med. 1993 Nov;10(9):839-42
8281729
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8
8197147
Diabetes. 1994 Nov;43(11):1271-8
7926300
J Biol Chem. 1995 Nov 10;270(45):26746-9
7592907
Atherosclerosis. 2000 Feb;148(2):209-14
10657556